EIF1AY Antibody (OTI2G2) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-71417DL594
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Western Blot
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Monoclonal Mouse IgG2A Clone # OTI2G2
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant protein fragment corresponding to amino acids 2-144 of human EIF1AY (NP_004672) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for EIF1AY Antibody (OTI2G2) [DyLight 594]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: EIF1AY
Alternate Names
eIF-1A Y isoform, eIF-4C, eukaryotic translation initiation factor 1A, Y chromosome, eukaryotic translation initiation factor 1A, Y-chromosomal, eukaryotic translation initiation factor 1A, Y-linked, Eukaryotic translation initiation factor 4C
Gene Symbol
EIF1AY
UniProt
Additional EIF1AY Products
Product Documents for EIF1AY Antibody (OTI2G2) [DyLight 594]
Product Specific Notices for EIF1AY Antibody (OTI2G2) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...